Back to search

United Kingdom· GB-APID-34610311000001103

Ravicti 1.1g/ml oral liquid

A glycerol phenylbutyrate product containing glycerol phenylbutyrate, registered in United Kingdom by Immedica Pharma AB. The same ATC class is registered in 13 of our 19 countries.

ATC A16AX09

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRavicti 1.1g/ml oral liquidATCA16AX09REGISTER NO.GB-APID-3461031100000…PACKS LISTED8CHECKEDSeptember 13, 2026

Where it is registered

Glycerol phenylbutyrate is registered in 13 of 19 countries.

Countries holding a registration under ATC A16AX09 (glycerol phenylbutyrate), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose

Glycerol phenylbutyrate · ATC A16AX09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Glycerol phenylbutyrate
Manufacturer
Immedica Pharma AB
Country
United Kingdom (GB)
ATC code
A16AX09
ATC class
Glycerol phenylbutyrate
Defined daily dose
15 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 8

  • gtin
    05397163000257
  • gtin
    5397163000257
  • gtin
    07350110580125
  • gtin
    07350110580231
  • gtin
    07350110580361
  • gtin
    5397163000363
  • gtin
    5397163000370
  • gtin
    5397163000387

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

244 interactions on record for glycerol phenylbutyrate.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glycerol phenylbutyrate · interactions on record

244 records

  • 5 severe
  • 235 moderate
  • 4 minor

Most severe, free to view

  • ProbenecidM04AB01severe
  • Valproic acidN03AG01severe
  • PantoprazoleA02BC02moderate
  • MetoclopramideA03FA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glycerol phenylbutyrate in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycerol phenylbutyrate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ravicti
  • Liechtenstein · Ravicti
  • Norway · Ravicti

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0ff90f94-1ac1-43a5-813b-6f394e64b83a
GET /v1/drugs/0ff90f94-1ac1-43a5-813b-6f394e64b83a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "34610311000001103",
  "desc": "Ravicti 1.1g/ml oral liquid (Immedica Pharma AB)",
  "form": "Gastroenteral or oral liquid",
  "vpid": "34610111000001100",
  "source": "dmd",
  "vtm_id": "34610511000001109",
  "strength": "1.1 gram",
  "substance": "Glycerol phenylbutyrate",
  "ingredient": "Glycerol phenylbutyrate",
  "supplier_code": "38020311000001101"
}

See everything about glycerol phenylbutyrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.